Cargando…
USP29-mediated HIF1α stabilization is associated with Sorafenib resistance of hepatocellular carcinoma cells by upregulating glycolysis
Understanding the mechanisms underlying evasive resistance in cancer is an unmet medical need to improve the efficacy of current therapies. In hepatocellular carcinoma (HCC), aberrant expression of hypoxia-inducible factor 1 α (HIF1α) and increased aerobic glycolysis metabolism are drivers of resist...
Autores principales: | Gao, Ruize, Buechel, David, Kalathur, Ravi K. R., Morini, Marco F., Coto-Llerena, Mairene, Ercan, Caner, Piscuoglio, Salvatore, Chen, Qian, Blumer, Tanja, Wang, Xueya, Dazert, Eva, Heim, Markus H., Hall, Michael N., Tang, Fengyuan, Christofori, Gerhard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285469/ https://www.ncbi.nlm.nih.gov/pubmed/34272356 http://dx.doi.org/10.1038/s41389-021-00338-7 |
Ejemplares similares
-
YAP/TAZ and ATF4 drive resistance to Sorafenib in hepatocellular carcinoma by preventing ferroptosis
por: Gao, Ruize, et al.
Publicado: (2021) -
Protocol to screen for Sorafenib resistance regulators using pooled lentiviral shRNA library and a Sorafenib-resistant hepatocellular carcinoma cell model
por: Gao, Ruize, et al.
Publicado: (2023) -
Integrative proteogenomic characterization of hepatocellular carcinoma across etiologies and stages
por: Ng, Charlotte K. Y., et al.
Publicado: (2022) -
LATS1 but not LATS2 represses autophagy by a kinase-independent scaffold function
por: Tang, Fengyuan, et al.
Publicado: (2019) -
Arginine reprograms metabolism in liver cancer via RBM39
por: Mossmann, Dirk, et al.
Publicado: (2023)